PT2836559T - Composição que compreende um diluente orgânico e um éter de celulose. - Google Patents

Composição que compreende um diluente orgânico e um éter de celulose.

Info

Publication number
PT2836559T
PT2836559T PT137176772T PT13717677T PT2836559T PT 2836559 T PT2836559 T PT 2836559T PT 137176772 T PT137176772 T PT 137176772T PT 13717677 T PT13717677 T PT 13717677T PT 2836559 T PT2836559 T PT 2836559T
Authority
PT
Portugal
Prior art keywords
composition
cellulose ether
organic diluent
diluent
organic
Prior art date
Application number
PT137176772T
Other languages
English (en)
Inventor
Adden Roland
L Sammler Robert
Brackhagen Meinolf
S Grasman Nicholas
Petermann Oliver
J Guillaudeu Steven
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Publication of PT2836559T publication Critical patent/PT2836559T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals
PT137176772T 2012-04-11 2013-04-08 Composição que compreende um diluente orgânico e um éter de celulose. PT2836559T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261622757P 2012-04-11 2012-04-11

Publications (1)

Publication Number Publication Date
PT2836559T true PT2836559T (pt) 2016-08-31

Family

ID=48142997

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137176772T PT2836559T (pt) 2012-04-11 2013-04-08 Composição que compreende um diluente orgânico e um éter de celulose.

Country Status (8)

Country Link
US (1) US9757465B2 (pt)
EP (1) EP2836559B1 (pt)
JP (1) JP6185559B2 (pt)
KR (1) KR102065326B1 (pt)
CN (1) CN104364329B (pt)
BR (1) BR112014021506B1 (pt)
PT (1) PT2836559T (pt)
WO (1) WO2013154980A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103619884B (zh) * 2011-06-14 2016-06-29 陶氏环球技术有限责任公司 包括纤维素醚的食品组合物
US9441117B2 (en) * 2012-03-20 2016-09-13 Basf Se Mixtures, methods and compositions pertaining to conductive materials
KR102160903B1 (ko) * 2012-07-17 2020-10-05 다우 글로벌 테크놀로지스 엘엘씨 고도로 치환된 하이드록시알킬 메틸셀룰로즈를 포함하는 고체 분산물
JP6342990B2 (ja) * 2013-04-12 2018-06-13 ダウ グローバル テクノロジーズ エルエルシー メチルセルロースの水溶液を調製するための方法
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
CN105530918A (zh) * 2013-09-25 2016-04-27 陶氏环球技术有限责任公司 包含有机液体稀释剂和特定羟烷基甲基纤维素的组合物
EP3094656B1 (en) * 2014-01-16 2019-07-17 Dow Global Technologies LLC Support materials for 3d printing
CN107667121A (zh) * 2015-06-05 2018-02-06 陶氏环球技术有限责任公司 纤维素醚粉末
BR112017024993A2 (pt) * 2015-06-05 2018-08-07 Dow Global Technologies Llc ?método para produção de éter tipo metilcelulose em forma de pó?.
CA2987627C (en) * 2015-06-09 2023-09-19 Dow Global Technologies Llc Support materials for 3d printing
CN113637088B (zh) * 2021-10-18 2021-12-24 高密银鹰新材料股份有限公司 一种减少纤维素醚生产过程中产生黑黄点的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613142A (en) 1948-05-11 1952-10-07 Sol B Wiczer Alcohol fuel gel
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
GB1144225A (en) * 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
GB8608080D0 (en) 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
EP0872233A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
US6261218B1 (en) * 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
US6235893B1 (en) * 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
EA005423B1 (ru) 1999-09-24 2005-02-24 Янссен Фармацевтика Н.В. Противовирусные композиции
KR20010097244A (ko) 2000-04-21 2001-11-08 유충식 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법
DE10038978A1 (de) * 2000-08-10 2002-02-21 Wolff Walsrode Ag Verfahren zur Herstellung von Alkylhydroxyalkylcellulose
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
DE10233788A1 (de) * 2002-07-25 2004-02-05 Wolff Cellulosics Gmbh & Co. Kg Cellulosederivate mit gel-artigen rheologischen Eigenschaften und Verfahren zur Herstellung derselben
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
US7666918B2 (en) 2004-03-17 2010-02-23 Dow Global Technologies, Inc. Foams made from interpolymers of ethylene/α-olefins
MXPA06013891A (es) 2004-05-28 2007-01-26 Pfizer Prod Inc Composiciones farmaceuticas con comportamiento potenciado.
MY148074A (en) * 2005-05-10 2013-02-28 Novartis Ag Pharmaceutical compositions comprising imatinib and a release retardant
WO2008042635A1 (en) * 2006-09-29 2008-04-10 Union Carbide Chemicals & Plastics Technology Corporation Quaternized cellulose ethers for personal care products
DE602007008470D1 (en) * 2006-10-17 2010-09-23 Bend Res Inc Off
US20080262216A1 (en) * 2007-04-20 2008-10-23 Shin-Etsu Chemical Co., Ltd. Hydroxyalkyl methylcellulose having solubility and thermoreversible gelation properties improved
WO2012051035A1 (en) * 2010-10-12 2012-04-19 Dow Global Technologies Llc Novel cellulose ethers and their use
US9757355B2 (en) * 2011-01-10 2017-09-12 Celgene Corporation Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
US9616036B2 (en) * 2012-04-11 2017-04-11 Dow Global Technologies Llc Sustained release dosage forms

Also Published As

Publication number Publication date
CN104364329A (zh) 2015-02-18
WO2013154980A1 (en) 2013-10-17
EP2836559A1 (en) 2015-02-18
KR20140144297A (ko) 2014-12-18
US9757465B2 (en) 2017-09-12
JP2015512941A (ja) 2015-04-30
KR102065326B1 (ko) 2020-01-13
CN104364329B (zh) 2016-08-17
JP6185559B2 (ja) 2017-08-23
EP2836559B1 (en) 2016-05-25
BR112014021506B1 (pt) 2020-06-16
US20150065548A1 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
HK1208238A1 (en) Glucagon-like-peptide-2 (glp-2) analogues -2(glp-2)
PT2836559T (pt) Composição que compreende um diluente orgânico e um éter de celulose.
GB201317141D0 (en) Well Isolation
EP2828162A4 (en) DISPLAYABLE TABLE SET
EP2926305A4 (en) TRANSLATION OF MULTI-DIMENSIONAL CODE
HK1180931A1 (en) An electro-pulsograph
EP2870426A4 (en) FOLDABLE SHADE
EP2848646A4 (en) CELLULOSE RESIN COMPOSITION
HUP1200534A3 (en) Coaxial loudspeker arrangemet
EP2807563A4 (en) NETWORK TROUBLESHOOTING
HK1202445A1 (en) New formulation
EP2847668A4 (en) EXECUTION OF MULTIPLE SIDE Tables
SG11201500989SA (en) An Antifungal Compound
HK1207454A1 (en) Field analyzer
GB201214826D0 (en) Oxidised cellulose
EP2881792A4 (en) PELLICLE
SG11201504433VA (en) Silicone-compatible photoinitiators
PL2711141T3 (pl) Składany stół montażowy
GB201220661D0 (en) RF Transformer
HK1201692A1 (en) Antifungal agent
GB2508001B (en) RF transformer
EP2911002A4 (en) RESIST COMPOSITION
EP2799403A4 (en) TUBULAR DIGESTER
GB201214413D0 (en) Festivalstand (festistand)
GB201322031D0 (en) Trestle assembly